Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tiersten

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Gynecologic Oncology|January 14, 2009
Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009Amy D Tiersten, P Y Liu, Harriet O Smith, et al.
Cancer|January 28, 2003
A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinomaAmy D Tiersten, Caron Nelsen, Susan Talbot, et al.
Gynecologic Oncology|February 10, 2004
Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinomaAmy D Tiersten, Meredith J Selleck, Dawn L Hershman, et al.
The Journal of Dermatologic Surgery and Oncology|January 1, 1991
Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndromeA D Tiersten, C M Grin, A W Kopf, et al.
Gynecologic Oncology|June 16, 2010
A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: a Gynecologic Oncology Group studyAmy D Tiersten, Michael W Sill, Danielle Knight, et al.
Gynecologic Oncology|May 26, 2009
Southwest Oncology Group Trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancerHarriet O Smith, James Moon, Sharon P Wilczynski, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Gynecologic Oncology|January 14, 2009
Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009Amy D Tiersten, P Y Liu, Harriet O Smith, et al.
Cancer|January 28, 2003
A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinomaAmy D Tiersten, Caron Nelsen, Susan Talbot, et al.
Gynecologic Oncology|February 10, 2004
Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinomaAmy D Tiersten, Meredith J Selleck, Dawn L Hershman, et al.
The Journal of Dermatologic Surgery and Oncology|January 1, 1991
Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndromeA D Tiersten, C M Grin, A W Kopf, et al.
Gynecologic Oncology|June 16, 2010
A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: a Gynecologic Oncology Group studyAmy D Tiersten, Michael W Sill, Danielle Knight, et al.
Gynecologic Oncology|May 26, 2009
Southwest Oncology Group Trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancerHarriet O Smith, James Moon, Sharon P Wilczynski, et al.
Pageof 2